Main menu

Oxford Nanopore prevails for fourth time in patent hearing


Oxford Nanopore has prevailed once again following the decision yesterday by the European Patent Office (EPO) to revoke a second PacBio European Patent, EP3170904. This decision is consistent with that of an earlier EPO decision revoking PacBio European Patent EP3045542, as well as rulings from the ITC and US Court of Appeal that the claims of the respective patents were not entitled to a broad interpretation of the term ‘single molecule sequencing’.

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Nanopore technology

Subscribe to Nanopore updates Resources and publications What is the Nanopore Community

About Oxford Nanopore

News Company timeline Sustainability Leadership team Media resources & contacts For investors For partners Working at Oxford Nanopore Current vacancies Commercial information BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
English flag